Compare PSIX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | WVE |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | Singapore |
| Employees | 1000 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 929.2M | 1.1B |
| IPO Year | N/A | 2015 |
| Metric | PSIX | WVE |
|---|---|---|
| Price | $32.58 | $6.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 16 |
| Target Price | ★ $99.95 | $29.81 |
| AVG Volume (30 Days) | 380.1K | ★ 3.1M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,704,000.00 |
| Revenue This Year | $24.73 | N/A |
| Revenue Next Year | $16.20 | $85.67 |
| P/E Ratio | $17.20 | ★ N/A |
| Revenue Growth | N/A | ★ 149.43 |
| 52 Week Low | $31.90 | $5.02 |
| 52 Week High | $121.47 | $21.73 |
| Indicator | PSIX | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 32.01 | 49.32 |
| Support Level | N/A | $6.02 |
| Resistance Level | $43.75 | $6.48 |
| Average True Range (ATR) | 1.99 | 0.33 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 8.71 | 60.54 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.